Related Experiment Videos
Pathological anatomy and molecular pathology
Michael Krismann1, Klaus-Michael Müller, Malgorzata Jaworska
1Institute of Pathology, University Clinic Bergmannsheil Bochum, Bürkle-de-la-Camp-Platz 1, D-44789, Germany. michael.krismann@ruhr-uni-bochum.de
Lung Cancer (Amsterdam, Netherlands)
|July 21, 2004
Summary
Malignant mesothelioma incidence is rising in Germany due to past asbestos exposure. Reliable diagnosis, crucial for treatment and legal matters, relies on histology, immunohistochemistry, and potentially DNA cytometry, as new markers like TERT showed limited diagnostic value.
Area of Science:
- Oncology
- Pathology
- Occupational Health
Background:
- Malignant mesothelioma incidence in Germany has risen since the mid-1980s, projected to peak around 2020.
- Approximately 90% of mesotheliomas are asbestos-related, often linked to occupational exposure during peak asbestos processing years (1965-1980).
- In 2003, the German Mesothelioma Registry diagnosed 717 new cases, highlighting the disease's public health impact.
Purpose of the Study:
- To evaluate diagnostic markers for malignant mesothelioma.
- To assess the utility of telomerase reverse transcriptase catalytic subunit (TERT) and DNA cytometry in differentiating neoplastic from reactive mesothelial lesions.
- To underscore the importance of accurate pathological diagnosis for patient management.
Main Methods:
- Review of cases from the German Mesothelioma Registry.
- Histopathological and immunohistochemical analysis, the current diagnostic gold standard.
- Investigation of telomerase reverse transcriptase catalytic subunit (TERT) expression.
- DNA cytometric analysis.
- Comparative genomic hybridization (CGH) for chromosomal abnormalities.
Main Results:
- The study could not confirm TERT as a reliable marker for differentiating reactive from neoplastic mesothelial lesions.
- DNA cytometry showed potential in distinguishing between reactive and neoplastic mesothelial lesions.
- Characteristic chromosomal imbalance patterns were observed via CGH, but specific causative genetic defects remain unknown.
- Conventional histology with immunohistochemistry remains the gold standard for diagnosis.
Conclusions:
- Accurate pathological diagnosis of mesothelioma is essential for guiding therapy, prognosis, and medicolegal assessments.
- While TERT was not found to be a definitive diagnostic marker, DNA cytometry and CGH offer potential adjunctive diagnostic tools.
- Thoracoscopic biopsy and detailed pathological descriptions are crucial for individualized patient treatment strategies.